Filing Details

Accession Number:
0001225208-20-006951
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-01 15:56:26
Reporting Period:
2020-04-29
Accepted Time:
2020-05-01 15:56:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1488270 M Douglas Lankler Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-04-29 7,901 $38.01 135,375 No 4 S Direct
Common Stock Disposition 2020-04-29 57,099 $37.83 78,276 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,561 Indirect By Rule 16b-3 Plan